Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vivus
Pharma
ICER put four recent obesity meds under a microscope
Novo Nordisk’s weight loss newcomer Wegovy may not be the thriftiest obesity med on the market, but its efficacy and safety look good, ICER says.
Fraiser Kansteiner
Jul 13, 2022 9:30am
FDA rebukes Metuchen for 'misleading' Stendra ads
Aug 29, 2019 4:03pm
FDA's promo police ding Vivus for misleading Qsymia webpage
Jun 6, 2019 12:43pm
Vivus, diving into CF, backs stadium step-climbing fundraiser
Sep 27, 2018 11:05am
Novo preps big obesity push, undeterred by its rivals' fates
Nov 21, 2017 11:57am
Sanofi wipes its hands of Vivus ED med Stendra
Mar 29, 2017 9:55am
